FEDERICI, MASSIMO
FEDERICI, MASSIMO
Dipartimento di Medicina dei sistemi
2-hydroxycaproate predicts cardiovascular mortality in patients with atherosclerotic disease
2018-01-01 Cardellini, M; Ballanti, M; Davato, F; Cardolini, I; Guglielmi, V; Rizza, S; Pecchioli, C; Casagrande, V; Mavilio, M; Porzio, O; Legramante, Jm; Ippoliti, A; Farcomeni, A; Sbraccia, P; Menghini, R; Dumas, Me; Kappel, Ba; Federici, M
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
2019-08-31 Cosentino, F; Grant, Pj; Aboyans, V; Bailey, Cj; Ceriello, A; Delgado, V; Federici, M; Filippatos, G; Grobbee, De; Hansen, Tb; Huikuri, Hv; Johansson, I; Jüni, P; Lettino, M; Marx, N; Mellbin, Lg; Östgren, Cj; Rocca, B; Roffi, M; Sattar, N; Seferović, Pm; Sousa-Uva, M; Valensi, P; Wheeler, Dc
A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects
2003-05-01 Sesti, G; Cardellini, M; Marini, Ma; Frontoni, S; D'Adamo, M; Del Guerra, S; Lauro, D; De Nicolais, P; Sbraccia, P; Del Prato, S; Gambardella, S; Federici, M; Marchetti, P; Lauro, R
A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects
2003-05-01 Sesti, G; Cardellini, M; Marini, Ma; Frontoni, S; D'Adamo, M; Del Guerra, S; Lauro, D; De Nicolais, P; Sbraccia, P; Del Prato, S; Gambardella, S; Federici, M; Marchetti, P; Lauro, R
A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects
2003-05-01 Sesti, G; Cardellini, M; Marini, Ma; Frontoni, S; D'Adamo, M; Del Guerra, S; Lauro, D; De Nicolais, P; Sbraccia, P; Del Prato, S; Gambardella, S; Federici, M; Marchetti, P; Lauro, R
A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury after ischemia-reperfusion in the mouse
2014-04-01 Marchetti, C; Chojnacki, J; Toldo, S; Mezzaroma, E; Tranchida, N; Rose, S; Federici, M; Van Tassell, B; Zhang, S; Abbate, A
A1c value for diabetes diagnosis in subjects with established cardiovascular disease
2015-01-01 Luzi, A; Rizza, S; Cardellini, M; Pecchioli, C; DI COLA, G; Davato, F; Porzio, O; Ippoliti, A; Copetti, M; Federici, M
Accelerated lipid-induced atherogenesis in galectin-3-deficient mice: Role of lipoxidation via receptor-mediated mechanisms
2009-01-01 Iacobini, C; Menini, S; Ricci, C; Scipioni, A; Sansoni, V; Cordone, S; Taurino, M; Serino, M; Marano, G; Federici, M; Pricci, F; Pugliese, G
Accelerated lipid-induced atherogenesis in galectin-3-deficient mice: role of lipoxidation via receptor-mediated mechanisms
2009-06-01 Iacobini, C; Menini, S; Ricci, C; Scipioni, A; Sansoni, V; Cordone, S; Taurino, M; Serino, M; Marano, G; Federici, M; Pricci, F; Pugliese, G
Activation of the hexosamine pathway leads to phosphorylation of insulin receptor substrate-1 on Ser(307) and Ser(612) and impairs the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin insulin biosynthetic pathway in RIN pancreatic beta-cells
2004-01-01 Andreozzi, F; D'Alessandris, C; Federici, M; Laratta, E; Del Guerra, S; Del Prato, S; Marchetti, P; Lauro, R; Perticone, F; Sesti, G
Adiponectin isoforms are not associated with the severity of coronary atherosclerosis but with undiagnosed diabetes in patients affected by stable CAD
2009-01-01 Rizza, S; Clementi, F; Porzio, O; Cardellini, M; Savo, A; Serino, M; Chiricolo, G; Romeo, F; Lauro, R; Federici, M
Adiponectin isoforms in elderly patients with or without coronary artery disease
2010-04-01 Rizza, S; Gigli, F; Galli, A; Micchelini, B; Lauro, D; Lauro, R; Federici, M
Age-Related Different Relationships between Ectopic Adipose Tissues and Measures of Central Obesity in Sedentary Subjects
2014-07-22 Guglielmi, V; Maresca, L; D'Adamo, M; Di Roma, M; Lanzillo, C; Federici, M; Lauro, D; Preziosi, P; Bellia, A; Sbraccia, P
Alterations in Rev-ERBα/BMAL1 ratio and glycated hemoglobin in rotating shift workers: the EuRhythDia study
2021-03-31 Rizza, S; Luzi, A; Mavilio, M; Ballanti, M; Massimi, A; Porzio, O; Magrini, A; Hannemann, J; Menghini, R; Lehrke, M; Staels, B; Grant, Pj; Boger, Rh; Marx, N; Federici, M
The angiogenic factor PIGF mediates a neuroimmune interaction in the spleen to allow the onset of hypertension
2014-01-01 Carnevale, D; Pallante, F; Fardella, V; Fardella, S; Iacobucci, R; Federici, M; Cifelli, G; Delucia, M; Lembo, G
The APOA1bp-SREBF-NOTCH axis is associated with reduced atherosclerosis risk in morbidly obese patients
2020-11-01 Mayneris-Perxachs, J; Puig, J; Burcelin, R; Dumas, M; Barton, Rh; Hoyles, L; Federici, M; Fernández-Real, J
Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction.
2003-01-01 Mango, R; Clementi, F; Borgiani, P; Forleo, G; Federici, M; Contino, G; Giardina, E; Garza, L; Fahdi, I; Lauro, R; Mehta, J; Novelli, G; Romeo, F
Association of Urinary and Plasma Levels of Trimethylamine N-Oxide (TMAO) with Foods
2021-04-23 Lombardo, M; Aulisa, G; Marcon, D; Rizzo, G; Tarsisano, Mg; Di Renzo, L; Federici, M; Caprio, M; De Lorenzo, A
Atherosclerosis severity but not undiagnosed diabetes predicts new cardiovascular events of subjects in secondary cardiovascular prevention.
2012-01-01 Rizza, S; Copetti, M; Cardellini, M; Porzio, O; Luzi, A; Pecchioli, C; Martelli, E; Valentini, A; Ippoliti, A; Romeo, F; Pellegrini, F; Lauro, D; Lauro, R; Federici, M
Autoantibodies against the glial glutamate transporter GLT1/EAAT2 in Type 1 diabetes mellitus-Clues to novel immunological and non-immunological therapies
2022-03-01 Perego, C; Di Cairano, Es; Galli, A; Moretti, S; Bazzigaluppi, E; Centonze, Vf; Gastaldelli, A; Assi, E; Fiorina, P; Federici, M; Porzio, O; Bertuzzi, F; Davalli, Am; Folli, F
Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
---|---|---|---|---|
1-gen-2018 | 2-hydroxycaproate predicts cardiovascular mortality in patients with atherosclerotic disease | Cardellini, M; Ballanti, M; Davato, F; Cardolini, I; Guglielmi, V; Rizza, S; Pecchioli, C; Casagrande, V; Mavilio, M; Porzio, O; Legramante, Jm; Ippoliti, A; Farcomeni, A; Sbraccia, P; Menghini, R; Dumas, Me; Kappel, Ba; Federici, M | Articolo su rivista | |
31-ago-2019 | 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD | Cosentino, F; Grant, Pj; Aboyans, V; Bailey, Cj; Ceriello, A; Delgado, V; Federici, M; Filippatos, G; Grobbee, De; Hansen, Tb; Huikuri, Hv; Johansson, I; Jüni, P; Lettino, M; Marx, N; Mellbin, Lg; Östgren, Cj; Rocca, B; Roffi, M; Sattar, N; Seferović, Pm; Sousa-Uva, M; Valensi, P; Wheeler, Dc | Articolo su rivista | |
1-mag-2003 | A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects | Sesti, G; Cardellini, M; Marini, Ma; Frontoni, S; D'Adamo, M; Del Guerra, S; Lauro, D; De Nicolais, P; Sbraccia, P; Del Prato, S; Gambardella, S; Federici, M; Marchetti, P; Lauro, R | Articolo su rivista | |
1-mag-2003 | A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects | Sesti, G; Cardellini, M; Marini, Ma; Frontoni, S; D'Adamo, M; Del Guerra, S; Lauro, D; De Nicolais, P; Sbraccia, P; Del Prato, S; Gambardella, S; Federici, M; Marchetti, P; Lauro, R | Articolo su rivista | |
1-mag-2003 | A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects | Sesti, G; Cardellini, M; Marini, Ma; Frontoni, S; D'Adamo, M; Del Guerra, S; Lauro, D; De Nicolais, P; Sbraccia, P; Del Prato, S; Gambardella, S; Federici, M; Marchetti, P; Lauro, R | Articolo su rivista | |
1-apr-2014 | A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury after ischemia-reperfusion in the mouse | Marchetti, C; Chojnacki, J; Toldo, S; Mezzaroma, E; Tranchida, N; Rose, S; Federici, M; Van Tassell, B; Zhang, S; Abbate, A | Articolo su rivista | |
1-gen-2015 | A1c value for diabetes diagnosis in subjects with established cardiovascular disease | Luzi, A; Rizza, S; Cardellini, M; Pecchioli, C; DI COLA, G; Davato, F; Porzio, O; Ippoliti, A; Copetti, M; Federici, M | Articolo su rivista | |
1-gen-2009 | Accelerated lipid-induced atherogenesis in galectin-3-deficient mice: Role of lipoxidation via receptor-mediated mechanisms | Iacobini, C; Menini, S; Ricci, C; Scipioni, A; Sansoni, V; Cordone, S; Taurino, M; Serino, M; Marano, G; Federici, M; Pricci, F; Pugliese, G | Articolo su rivista | |
1-giu-2009 | Accelerated lipid-induced atherogenesis in galectin-3-deficient mice: role of lipoxidation via receptor-mediated mechanisms | Iacobini, C; Menini, S; Ricci, C; Scipioni, A; Sansoni, V; Cordone, S; Taurino, M; Serino, M; Marano, G; Federici, M; Pricci, F; Pugliese, G | Articolo su rivista | |
1-gen-2004 | Activation of the hexosamine pathway leads to phosphorylation of insulin receptor substrate-1 on Ser(307) and Ser(612) and impairs the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin insulin biosynthetic pathway in RIN pancreatic beta-cells | Andreozzi, F; D'Alessandris, C; Federici, M; Laratta, E; Del Guerra, S; Del Prato, S; Marchetti, P; Lauro, R; Perticone, F; Sesti, G | Articolo su rivista | |
1-gen-2009 | Adiponectin isoforms are not associated with the severity of coronary atherosclerosis but with undiagnosed diabetes in patients affected by stable CAD | Rizza, S; Clementi, F; Porzio, O; Cardellini, M; Savo, A; Serino, M; Chiricolo, G; Romeo, F; Lauro, R; Federici, M | Articolo su rivista | |
1-apr-2010 | Adiponectin isoforms in elderly patients with or without coronary artery disease | Rizza, S; Gigli, F; Galli, A; Micchelini, B; Lauro, D; Lauro, R; Federici, M | Articolo su rivista | |
22-lug-2014 | Age-Related Different Relationships between Ectopic Adipose Tissues and Measures of Central Obesity in Sedentary Subjects | Guglielmi, V; Maresca, L; D'Adamo, M; Di Roma, M; Lanzillo, C; Federici, M; Lauro, D; Preziosi, P; Bellia, A; Sbraccia, P | Articolo su rivista | |
31-mar-2021 | Alterations in Rev-ERBα/BMAL1 ratio and glycated hemoglobin in rotating shift workers: the EuRhythDia study | Rizza, S; Luzi, A; Mavilio, M; Ballanti, M; Massimi, A; Porzio, O; Magrini, A; Hannemann, J; Menghini, R; Lehrke, M; Staels, B; Grant, Pj; Boger, Rh; Marx, N; Federici, M | Articolo su rivista | |
1-gen-2014 | The angiogenic factor PIGF mediates a neuroimmune interaction in the spleen to allow the onset of hypertension | Carnevale, D; Pallante, F; Fardella, V; Fardella, S; Iacobucci, R; Federici, M; Cifelli, G; Delucia, M; Lembo, G | Articolo su rivista | |
1-nov-2020 | The APOA1bp-SREBF-NOTCH axis is associated with reduced atherosclerosis risk in morbidly obese patients | Mayneris-Perxachs, J; Puig, J; Burcelin, R; Dumas, M; Barton, Rh; Hoyles, L; Federici, M; Fernández-Real, J | Articolo su rivista | |
1-gen-2003 | Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction. | Mango, R; Clementi, F; Borgiani, P; Forleo, G; Federici, M; Contino, G; Giardina, E; Garza, L; Fahdi, I; Lauro, R; Mehta, J; Novelli, G; Romeo, F | Articolo su rivista | |
23-apr-2021 | Association of Urinary and Plasma Levels of Trimethylamine N-Oxide (TMAO) with Foods | Lombardo, M; Aulisa, G; Marcon, D; Rizzo, G; Tarsisano, Mg; Di Renzo, L; Federici, M; Caprio, M; De Lorenzo, A | Articolo su rivista | |
1-gen-2012 | Atherosclerosis severity but not undiagnosed diabetes predicts new cardiovascular events of subjects in secondary cardiovascular prevention. | Rizza, S; Copetti, M; Cardellini, M; Porzio, O; Luzi, A; Pecchioli, C; Martelli, E; Valentini, A; Ippoliti, A; Romeo, F; Pellegrini, F; Lauro, D; Lauro, R; Federici, M | Articolo su rivista | |
1-mar-2022 | Autoantibodies against the glial glutamate transporter GLT1/EAAT2 in Type 1 diabetes mellitus-Clues to novel immunological and non-immunological therapies | Perego, C; Di Cairano, Es; Galli, A; Moretti, S; Bazzigaluppi, E; Centonze, Vf; Gastaldelli, A; Assi, E; Fiorina, P; Federici, M; Porzio, O; Bertuzzi, F; Davalli, Am; Folli, F | Articolo su rivista |